An underground economy for unlicensed slimming medications is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.
Investigational Drug Gaining Traction Online
The experimental drug, which is still in research studies, is being advertised by online personalities for its supposed weight-reducing effects. Viewers are urged to message these accounts directly for source information, while also receiving discount codes.
Thriving Commerce on Social Networks
Additionally, a flourishing trade exists on messaging services, where communities with thousands of members share comparison images, administration instructions and claims of next-day British shipping. Vendors promote the drug there before redirecting buyers to other platforms for purchases.
Understanding Retatrutide
Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Healthcare Experts Express Concerns
However, doctors and pharmacists have warned that the sale of what is still an unapproved drug in the UK is a cause for concern and could lead to users administering products of unknown origin.
Some experts said the popularity for retatrutide could be linked to the increasing cost of approved slimming products such as Mounjaro.
Regulatory Position and Enforcement
Marketing retatrutide on social media or messaging apps is illegal in the UK, as it is an unapproved medication that must not be promoted or supplied for personal consumption under the British medical regulations.
Several content creators try to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but advertising and distribution can still violate medicines, advertising, and consumer laws, potentially leading to penalties, prosecution or imprisonment.
Service Response and Material Removal
Based on TikTok, the service has removed violative content and prohibited related hashtags and query recommendations. The organization stated it was dedicated to maintaining the platform secure and allocating resources in strengthening enforcement strategies.
Online Marketplace Operations
Investigations also discovered groups with up to nine thousand participants selling retatrutide using Telegram's integrated discovery tool, which operates like a public directory. Entering “retatrutide” immediately brings up groups with thousands of members, filled with photos of weight loss, positive reviews and detailed guides for mixing or administering at residence.
Within minutes of joining one community, a vendor posted WhatsApp details, where most purchases occur. The vendor provided an guidebook and promised delivery within two days. When asked whether the substance was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None inquired about weight, health issues or past usage.
Item Details and Pricing
Within these groups, messages show dark colored parcels with Royal Mail stickers, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at home with purified liquid, or ready-to-use pens usually sold at 160 pounds for 20mg. When asked how much time a pen should be used, vendors give conflicting answers varying between a few weeks to “depends on your body”.
Platform Moderation and Security Measures
A representative for Telegram stated it regularly monitored dangerous content on its platform including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are injecting materials they can’t verify. Although the science behind this drug is sound, these online versions may not include what they advertise,” said Jason Murphy, the director of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor linked the surge in demand to current price rises for approved slimming medications such as Mounjaro. “With costs increasing, patients are using social media. But counterfeit treatments are highly risky. You cannot know what’s contained or whether the environment they were made in was sterile,” she explained.
Her staff has already seen patients harmed by self-injection from unconfirmed sources. “We recognize the frustration, but purchasing from Telegram or communication platforms is taking chances with your well-being,” said the doctor. “These substances could be impure or improperly measured.”
Producer Position
A spokesperson from the pharmaceutical company said the substance was in phase 3 research studies and had not been evaluated or authorized by any government authority globally. “Therefore at this point no one can market [it] for human use,” they said, noting that any product “misleadingly claiming itself as a company investigational product not yet authorized … may expose patients to potentially significant health risks”.
